Adoptive immunotherapy with donor lymphocyte infusionsafter allogeneic HPC transplantation
- 1 April 2000
- journal article
- review article
- Published by Wiley in Transfusion
- Vol. 40 (4) , 468-476
- https://doi.org/10.1046/j.1537-2995.2000.40040468.x
Abstract
No abstract availableThis publication has 64 references indexed in Scilit:
- TrueLeukemia, 1999
- Chemotherapy does not nullify the ability of donor lymphocyte infusions to mediate graft-versus-host reactionsBone Marrow Transplantation, 1998
- Complete cytogenetic response with host-derived hematopoiesis induced by cyclosporin A discontinuation in a patient with relapsed chronic myelogenous leukemia after bone marrow transplantationBone Marrow Transplantation, 1997
- Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patientsBone Marrow Transplantation, 1997
- Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.Journal of Clinical Investigation, 1995
- Donor T Cells to Treat EBV-Associated LymphomaNew England Journal of Medicine, 1994
- SELECTIVE DEPLETION OF CD8+ CELLS FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER BONE MARROW TRANSPLANTATION A RANDOMIZED CONTROLLED TRIALTransplantation, 1994
- Graft-versus-Host Disease as Adoptive Immunotherapy in Patients with Advanced Hematologic NeoplasmsNew England Journal of Medicine, 1989
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1981
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979